Alkermes Plc
XMUN:8AK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alkermes Plc
XMUN:8AK
|
IE |
|
C
|
Canadian Utilities Ltd
TSX:CU
|
CA |
|
Eurocommercial Properties NV
AEX:ECMPA
|
NL |
|
Arizona Silver Exploration Inc
F:A9J
|
CA |
|
S
|
Samsung Special Purpose Acquisition 6 Co
KOSDAQ:425290
|
KR |
|
Power Group Projects Corp
XTSX:PGP
|
CA |
|
V
|
VerticalScope Holdings Inc
F:7E9
|
CA |
|
B
|
BREMER LAGERHAUS-GESELLSCHAFT AG von 1877
XBER:BLH
|
DE |
|
K
|
Kiwoom Hero No.1 Special Purpose Acquisition Co
KOSDAQ:466690
|
KR |
|
G
|
Great Plains Metals Corp
XTSX:GPS
|
CA |
|
C
|
Canter Resources Corp
OTC:CNRCF
|
CA |
|
K
|
KRP Development Holdings Ltd
HKEX:2421
|
CN |
|
E
|
Elia Group SA
DUS:E4S
|
BE |
|
Urbana Corp
F:2YY0
|
CA |
|
Active Energy Group PLC
OTC:AEUSF
|
UK |
|
C
|
China Beidahuang Industry Group Holdings Ltd
HKEX:39
|
HK |
|
Q
|
Quantum Corp
F:QNT2
|
US |
Bankruptcy Probability
Alkermes Plc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Alkermes Plc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IE |
|
Alkermes Plc
NASDAQ:ALKS
|
8.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
65.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Alkermes Plc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Alkermes Plc has total debt of 1.5B USD. This includes both short-term (0 USD) and long-term (1.5B USD) debt.
You can find a full breakdown on its Balance Sheet.
